Patents by Inventor Garry L. Myers

Garry L. Myers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150174106
    Abstract: The present invention relates to compositions relating to films containing active pharmaceutical agents. In particular, the present invention relates to methods and systems useful for stabilizing amine-containing actives for dispersion in a film product.
    Type: Application
    Filed: March 2, 2015
    Publication date: June 25, 2015
    Inventors: Garry L. Myers, Madhusudan Hariharan, Kevin Davidson, Pradeep Sanghvi
  • Publication number: 20150164801
    Abstract: The present invention relates to rapid dissolve thin film drug delivery compositions for the oral administration of active components. The active components are provided as taste-masked or controlled-release coated particles uniformly distributed throughout the film composition. The compositions may be formed by wet casting methods, where the film is cast and controllably dried, or alternatively by an extrusion method.
    Type: Application
    Filed: December 16, 2014
    Publication date: June 18, 2015
    Inventors: Robert K. Yang, Richard C. Fuisz, Garry L. Myers, Joseph M. Fuisz
  • Publication number: 20150150825
    Abstract: The present invention relates to a method for forming a pharmaceutical product, such as a dissolvable film dosage form, onto a surface. Particularly, the present invention relates to a method of forming a pharmaceutical product directly onto the surface of a substrate.
    Type: Application
    Filed: January 15, 2015
    Publication date: June 4, 2015
    Inventors: Garry L. Myers, Beuford A. Bogue, Greg Slominski, Kevin Davidson, Laura Miloshoff
  • Patent number: 8974826
    Abstract: A therapeutic or bioeffecting film delivery system which includes nanoparticles having actives bound to or associated with the nanoparticles and which when administered allow the active to perform a therapeutic or bioeffecting function.
    Type: Grant
    Filed: June 10, 2011
    Date of Patent: March 10, 2015
    Assignees: Monosol RX, LLC, Midatech Limited
    Inventors: Alexander M. Schobel, Garry L. Myers, Keith Joseph Kendall, Thomas Rademacher, Jan Mous, Justin N. W. Barry, Phillip Williams, Africa Garcia Barrientos
  • Publication number: 20150056268
    Abstract: The present invention relates to water-soluble films incorporating anti-tacking agents and methods of their preparation. Anti-tacking agents may improve the flow characteristics of the compositions and thereby reduce the problem of film adhering to a user's mouth or to other units of film. In particular, the present invention relates to edible water-soluble delivery systems in the form of a film composition including a water-soluble polymer, an active component selected from cosmetic agents, pharmaceutical agents, vitamins, bioactive agents and combinations thereof and at least one anti-tacking agent.
    Type: Application
    Filed: May 21, 2014
    Publication date: February 26, 2015
    Applicant: MonoSol Rx, LLC
    Inventors: Garry L. Myers, Pradeep Sanghvi, Andrew Philip Verrall, Vimala Francis, Laura Moss
  • Patent number: 8936825
    Abstract: The present invention relates to a method for forming a pharmaceutical product, such as a dissolvable film dosage form, onto a surface. Particularly, the present invention relates to a method of forming a pharmaceutical product directly onto the surface of a substrate.
    Type: Grant
    Filed: September 21, 2011
    Date of Patent: January 20, 2015
    Assignee: Monosol RX, LLC
    Inventors: Garry L. Myers, Beuford A. Bogue, Greg Slominski, Kevin Davidson, Laura Miloshoff
  • Publication number: 20140378497
    Abstract: The present invention relates to products and methods for treatment of narcotic dependence in a user. The invention more particularly relates to self-supporting dosage forms which provide an active agent for treating narcotic dependence while providing sufficient buccal adhesion of the dosage form.
    Type: Application
    Filed: September 5, 2014
    Publication date: December 25, 2014
    Applicant: Reckitt Benckiser Healthcare (UK) Limited
    Inventors: Garry L. Myers, Samuel D. Hilbert, Bill J. Boone, Beuford Arlie Bogue, Pradeep Sanghvi, Madhusudan Hariharan
  • Patent number: 8906277
    Abstract: The invention relates to film products containing desired levels of active components and methods of their preparation. Desirably, the films disintegrate in water and may be formed by a controlled drying process, or other process that maintains the required uniformity of the film. Desirably, the films may be exposed to temperatures above that at which the active components typically degrade without concern for loss of the desired activity.
    Type: Grant
    Filed: August 23, 2013
    Date of Patent: December 9, 2014
    Assignee: MonoSol Rx, LLC
    Inventors: Robert K. Yang, Richard C. Fuisz, Garry L. Myers, Joseph M. Fuisz
  • Patent number: 8900498
    Abstract: The invention relates to the film products and methods of their preparation that demonstrate a non-self-aggregating uniform heterogeneity. Desirably, the films disintegrate in water and may be formed by a controlled drying process, or other process that maintains the required uniformity of the film. The films contain a polymer component, which includes polyethylene oxide optionally blended with hydrophilic cellulosic polymers. Desirably, the films also contain a pharmaceutical and/or cosmetic active agent with no more than a 10% variance of the active agent pharmaceutical and/or cosmetic active agent per unit area of the film.
    Type: Grant
    Filed: August 23, 2013
    Date of Patent: December 2, 2014
    Assignee: MonoSol Rx, LLC
    Inventors: Robert K. Yang, Richard C. Fuisz, Garry L. Myers, Joseph M. Fuisz
  • Patent number: 8900497
    Abstract: The invention relates to the film products and methods of their preparation that demonstrate a non-self-aggregating uniform heterogeneity. Desirably, the films disintegrate in water and may be formed by a controlled drying process, or other process that maintains the required uniformity of the film. The films contain a polymer component, which includes polyethylene oxide optionally blended with hydrophilic cellulosic polymers. Desirably, the films also contain a pharmaceutical and/or cosmetic active agent with no more than a 10% variance of the active agent pharmaceutical and/or cosmetic active agent per unit area of the film.
    Type: Grant
    Filed: August 23, 2013
    Date of Patent: December 2, 2014
    Assignee: MonoSol Rx, LLC
    Inventors: Robert K. Yang, Richard C. Fuiz, Garry L. Myers, Joseph M. Fuiz
  • Publication number: 20140305835
    Abstract: An oral dosage delivery vehicle comprising an edible film including a uniformly distributed active ingredient, wherein said film comprises dosage units releasably joined by one or more weakened sections, which permit said dosage units to be detached from said film.
    Type: Application
    Filed: April 14, 2014
    Publication date: October 16, 2014
    Applicant: MONOSOL RX, LLC
    Inventors: Robert K. Yang, Richard C. Fuisz, Garry L. Myers
  • Publication number: 20140275194
    Abstract: The invention relates to film products including a polymer component and a therapeutically effective amount of rizatriptan or a pharmaceutically acceptable salt thereof. The invention further relates to film products including a polymer component and a therapeutically effective amount of rizatriptan benzoate.
    Type: Application
    Filed: March 15, 2013
    Publication date: September 18, 2014
    Inventors: Eric Dadey, Alexander Mark Schobel, Daniel R. Barber, Garry L. Myers
  • Publication number: 20140271867
    Abstract: The present invention includes a pharmaceutical-based film system which includes various small-scale forms of pharmaceutically active agents, including testosterone esters, in a film base. Such forms include nanoparticles, microparticles, and combinations thereof. Methods of producing such film and providing a dosage of the pharmaceutical in a film are also provided.
    Type: Application
    Filed: March 15, 2013
    Publication date: September 18, 2014
    Applicant: MONOSOL RX, LLC
    Inventor: Garry L. Myers
  • Publication number: 20140271789
    Abstract: The present invention relates to products and methods for treatment of various symptoms in a patient, including treatment of pain suffered by a patient. The invention more particularly relates to self-supporting dosage forms which provide an active agent while providing sufficient buccal adhesion of the dosage form. Further, the present invention provides a dosage form which is useful in reducing the likelihood of diversion abuse of the active agent.
    Type: Application
    Filed: March 4, 2014
    Publication date: September 18, 2014
    Applicant: MonoSol Rx, LLC
    Inventors: Garry L. Myers, Eric Dadey
  • Publication number: 20140248223
    Abstract: The invention relates to the film products and methods of their preparation that demonstrate a non-self-aggregating uniform heterogeneity. Desirably, the films disintegrate in water and may be formed by a controlled drying process, or other process that maintains the required uniformity of the film. Desirably, the films contain at least one active agent, which may be administered to a user topically, transmucosally, vaginally, ocularly, aurally, nasally, transdermally or orally.
    Type: Application
    Filed: March 3, 2014
    Publication date: September 4, 2014
    Applicant: MONOSOL RX, LLC
    Inventors: Garry L. Myers, Richard C. Fuisz
  • Patent number: 8765167
    Abstract: The present invention relates to water-soluble films incorporating anti-tacking agents and methods of their preparation. Anti-tacking agents may improve the flow characteristics of the compositions and thereby reduce the problem of film adhering to a user's mouth or to other units of film. In particular, the present invention relates to edible water-soluble delivery systems in the form of a film composition including a water-soluble polymer, an active component selected from cosmetic agents, pharmaceutical agents, vitamins, bioactive agents and combinations thereof and at least one anti-tacking agent.
    Type: Grant
    Filed: September 8, 2006
    Date of Patent: July 1, 2014
    Assignee: MonoSol Rx, LLC
    Inventors: Garry L. Myers, Pradeep Sanghvi, Andrew Philip Verrall, Vimala Francis, Laura Moss
  • Publication number: 20140103057
    Abstract: The packet dispenser includes a container structure having an interior cavity. The cavity has a sufficient dimension such that a packet structure may be stored therein. The container structure has an opening to the cavity through which the packet structure can be removed therefrom. A tear structure is connected to the container structure such that the packet structure may contact the tear structure to tear a portion thereof when the packet structure is removed from the cavity.
    Type: Application
    Filed: December 18, 2013
    Publication date: April 17, 2014
    Applicant: MonoSol Rx, LLC
    Inventors: Richard C. Fuisz, Bruce D. Detwiler, Garry L. Myers, Pradeep Sanghvi, Madhusudan Hariharan, Laura Moss
  • Patent number: 8685437
    Abstract: The invention relates to the film products and methods of their preparation that demonstrate a non-self-aggregating uniform heterogeneity. Desirably the films disintegrate in water and may be formed by a controlled drying process, or other process that maintains the required uniformity of the film.
    Type: Grant
    Filed: March 26, 2009
    Date of Patent: April 1, 2014
    Assignee: MonoSol Rx, LLC
    Inventors: Robert K. Yang, Richard C. Fuisz, Garry L. Myers, Joseph M. Fuisz
  • Publication number: 20140073678
    Abstract: In one aspect, the present invention discloses combinational compositions for treating users experiencing symptoms associated with a migraine or other central nervous system related pain disorder that can cause or exacerbate nausea and/or vomiting or other central nervous system related pain disorder that can cause or exacerbate nausea and/or vomiting. The combinational composition includes a first pharmaceutical active component for treating pain, and a second pharmaceutical active component for treating nausea and/or vomiting and/or vomiting in a user.
    Type: Application
    Filed: March 15, 2013
    Publication date: March 13, 2014
    Applicant: MONOSOL RX, LLC
    Inventors: Eric Dadey, Alexander Mark Schobel, Daniel R. Barber, Garry L. Myers
  • Patent number: 8663696
    Abstract: The present invention includes a pharmaceutical-based film system which includes various small-scale forms of pharmaceutically active agents, including tetrahydrolipstatin, in a film base. Such forms include nanoparticles, microparticles, and combinations thereof. Methods of producing such film and providing a dosage of the pharmaceutical in a film are also provided.
    Type: Grant
    Filed: August 17, 2012
    Date of Patent: March 4, 2014
    Assignee: MonoSol Rx, LLC
    Inventors: Garry L. Myers, Samuel D. Hilbert, Bill J. Boone